Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. PMID: 25918287 Journal: J CLIN ONCOL Year: 2015 Reference: J Clin Oncol. 2015 Jun 1;33(16):1787-96. doi: 10.1200/JCO.2014.60.0213. Epub 2015 Apr 27. Impact factor: Publication type: Review in national publication Authors: Dienstmann, Rodrigo; Salazar, Ramon; Tabernero, Josep et al. DOI: 10.1200/JCO.2014.60.0213 [Pertussis vaccine. Reemergence of the disease and new vaccination strategies]. PMID: 25707329 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2015 Reference: Enferm Infecc Microbiol Clin. 2015 Mar;33(3):190-6. doi: 10.1016/j.eimc.2015.02.001. Epub 2015 Feb 20. Impact factor: 2.172 Publication type: Paper in national publication Authors: Moraga-Llop, Fernando A, Campins-Marti, Magda et al. DOI: 10.1016/j.eimc.2015.02.001 [Pertussis vaccine. Reemergence of the disease and new vaccination strategies]. PMID: 25707329 Journal: ENFERM INFEC MICR CL Year: 2015 Reference: Enferm Infecc Microbiol Clin. 2015 Mar;33(3):190-6. doi: 10.1016/j.eimc.2015.02.001. Epub 2015 Feb 20. Impact factor: Publication type: Paper in national publication Authors: Campins-Marti, Magda; Moraga-Llop, Fernando A et al. DOI: 10.1016/j.eimc.2015.02.001 Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. PMID: 25693012 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2015 Reference: N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. Impact factor: 55.873 Publication type: Paper in international publication Authors: Grischke, E-M, Swain, Sandra M, Baselga, Jose, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas et al. DOI: 10.1056/NEJMoa1413513 Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. PMID: 25693012 Journal: NEW ENGL J MED Year: 2015 Reference: N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. Impact factor: Publication type: Paper in international publication Authors: Agajanian, R; Ahmad, R; Aktas, B; Alba Conejo, E; Amadori, D; Andrade, J; Angiolini, C; Aogi, K; Araujo, R; Armor, J F et al. DOI: 10.1056/NEJMoa1413513 Perylenetetracarboxylic anhydride as a precursor of fluorescent carbon nanoonion rings. PMID: 26135910 Journal: Nanoscale Year: 2015 Reference: Nanoscale. 2015 Aug 7;7(29):12484-91. doi: 10.1039/c5nr02903a. Epub 2015 Jul 2. Impact factor: 7.394 Publication type: Paper in international publication Authors: Garcia, Hermenegildo, Alvaro, Mercedes, Manuel Victor, Victor, Herance, Jose Raul, Baldovi, Herme G et al. DOI: 10.1039/c5nr02903a Perylenetetracarboxylic anhydride as a precursor of fluorescent carbon nanoonion rings. PMID: 26135910 Journal: NANOSCALE Year: 2015 Reference: Nanoscale. 2015 Aug 7;7(29):12484-91. doi: 10.1039/c5nr02903a. Epub 2015 Jul 2. Impact factor: Publication type: Paper in international publication Authors: Alvaro, Mercedes; Baldovi, Herme G; Garcia, Hermenegildo; Herance, Jose Raul; Manuel Victor, Victor et al. DOI: 10.1039/c5nr02903a Ph lb dose escalation study of oral pan-PI3K inhibitor buparlisib (BKM120) with oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with advanced solid tumours. PMID: 25500057 Journal: CLINICAL CANCER RESEARCH Year: 2015 Reference: Clin Cancer Res. 2015 Feb 15;21(4):730-8. doi: 10.1158/1078-0432.CCR-14-1814. Epub 2014 Dec 10. Impact factor: 8.722 Publication type: Paper in international publication Authors: Perez-Gercia, Jose, Bedard, Phillipe L, Tabernero, Josep, Janku, Filip, Wainberg, Zev A, Paz-Ares, Luis, Vansteenkiste, Johan, Van Cutsem, Eric, Le, Ngocdiep T, Carter, Kirsten et al. DOI: 10.1158/1078-0432.CCR-14-1814 Ph lb dose escalation study of oral pan-PI3K inhibitor buparlisib (BKM120) with oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with advanced solid tumours. PMID: 25500057 Journal: CLIN CANCER RES Year: 2015 Reference: Clin Cancer Res. 2015 Feb 15;21(4):730-8. doi: 10.1158/1078-0432.CCR-14-1814. Epub 2014 Dec 10. Impact factor: Publication type: Paper in international publication Authors: Bedard, Phillipe L; Britten, Carolyn D; Carter, Kirsten; Csonka, Denes; Demanse, David; Janku, Filip; Le, Ngocdiep T; Nauwelaerts, Heidi; Paz-Ares, Luis; Perez-Gercia, Jose et al. DOI: 10.1158/1078-0432.CCR-14-1814 Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-beta. PMID: 26445728 Journal: Neurology: Neuroimmunology & Neuroinflammation Year: 2015 Reference: Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e154. eCollection 2015 Oct. Impact factor: Publication type: Letter or abstract Authors: Bustamante, Marta F, Morcillo-Suarez, Carlos, Malhotra, Sunny, Rio, Jordi, Leyva, Laura, Fernandez, Oscar, Zettl, Uwe K, Killestein, Joep, Brassat, David, Garcia-Merino, Juan Antonio et al. DOI: 10.1212/NXI.0000000000000154 Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-beta. PMID: 26445728 Journal: Neurology(R) neuroimmunology & neuroinflammation Year: 2015 Reference: Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e154. eCollection 2015 Oct. Impact factor: Publication type: Letter or abstract Authors: Alvarez-Cermeno, Jose Carlos; Alvarez-Lafuente, Roberto; Brassat, David; Bustamante, Marta F; Chan, Andrew; Comabella, Manuel; Drulovic, Jelena S; Farre, Xavier; Fernandez, Oscar; Garcia-Merino, Juan Antonio et al. DOI: 10.1212/NXI.0000000000000154 Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer. PMID: 25988772 Journal: Expert Opinion on Drug Metabolism & Toxicology Year: 2015 Reference: Expert Opin Drug Metab Toxicol. 2015 Jun;11(6):995-1004. doi: 10.1517/17425255.2015.1041920. Impact factor: 2.831 Publication type: Paper in international publication Authors: Tabernero, Josep, Sanz-Garcia, Enrique, Sauri, Tamara, Macarulla, Teresa et al. DOI: 10.1517/17425255.2015.1041920 Pharmacokinetic and pharmacodynamic evaluation of aflibercept for the treatment of colorectal cancer. PMID: 25988772 Journal: EXPERT OPIN DRUG MET Year: 2015 Reference: Expert Opin Drug Metab Toxicol. 2015 Jun;11(6):995-1004. doi: 10.1517/17425255.2015.1041920. Impact factor: Publication type: Paper in international publication Authors: Macarulla, Teresa; Sanz-Garcia, Enrique; Sauri, Tamara; Tabernero, Josep et al. DOI: 10.1517/17425255.2015.1041920 Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-beta receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer. PMID: 25529192 Journal: INVESTIGATIONAL NEW DRUGS Year: 2015 Reference: Invest New Drugs. 2015 Apr;33(2):357-70. doi: 10.1007/s10637-014-0192-4. Epub 2014 Dec 23. Impact factor: 2.927 Publication type: Clinical Trials Authors: Baselga, Jose, Lahn, Michael M, Rodon, Jordi, Carducci, Michael, Sepulveda-Sanchez, Juan M, Azaro, Analia, Calvo, Emiliano, Brana, Irene, Sicart, Elisabet, Gueorguieva, Ivelina et al. DOI: 10.1007/s10637-014-0192-4 Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-beta receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer. PMID: 25529192 Journal: INVEST NEW DRUG Year: 2015 Reference: Invest New Drugs. 2015 Apr;33(2):357-70. doi: 10.1007/s10637-014-0192-4. Epub 2014 Dec 23. Impact factor: Publication type: Clinical Trials Authors: Azaro, Analia; Baselga, Jose; Blakeley, Jaishri; Brana, Irene; Calvo, Emiliano; Carducci, Michael; Cleverly, Ann; Desaiah, Durisala; Estrem, Shawn T; Gueorguieva, Ivelina et al. DOI: 10.1007/s10637-014-0192-4 Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. PMID: 25888060 Journal: CRITICAL CARE Year: 2015 Reference: Crit Care. 2015 Feb 4;19:33. doi: 10.1186/s13054-015-0758-3. Impact factor: 4.476 Publication type: Paper in international publication Authors: Roberts, Jason A, Sinnollareddy, Mahipal G, Bassetti, Matteo, De Waele, Jan J, Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew et al. DOI: 10.1186/s13054-015-0758-3 Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. PMID: 25888060 Journal: CRIT CARE Year: 2015 Reference: Crit Care. 2015 Feb 4;19:33. doi: 10.1186/s13054-015-0758-3. Impact factor: Publication type: Paper in international publication Authors: Akova, Murat; Bassetti, Matteo; De Waele, Jan J; Dimopoulos, George; Kaukonen, Kirsi-Maija; Koulenti, Despoina; Lipman, Jeffrey; Martin, Claude; Montravers, Philippe; Rello, Jordi et al. DOI: 10.1186/s13054-015-0758-3 Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes. PMID: 26212547 Journal: BIOCHEMICAL PHARMACOLOGY Year: 2015 Reference: Biochem Pharmacol. 2015 Nov 1;98(1):16-28. doi: 10.1016/j.bcp.2015.06.032. Epub 2015 Jul 23. Impact factor: 5.009 Publication type: Paper in international publication Authors: Zamora, Monica, Pardo, Rosario, Villena, Josep A et al. DOI: 10.1016/j.bcp.2015.06.032 Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes. PMID: 26212547 Journal: BIOCHEM PHARMACOL Year: 2015 Reference: Biochem Pharmacol. 2015 Nov 1;98(1):16-28. doi: 10.1016/j.bcp.2015.06.032. Epub 2015 Jul 23. Impact factor: Publication type: Paper in international publication Authors: Pardo, Rosario; Villena, Josep A; Zamora, Monica et al. DOI: 10.1016/j.bcp.2015.06.032 [PHARMACONUTRITION IN SEVERELY ILL PATIENT]. PMID: 26268074 Journal: Nutricion Hospitalaria Year: 2015 Reference: Nutr Hosp. 2015 Aug 1;32(2):478-86. doi: 10.3305/nh.2015.32.2.9324. Impact factor: 1.04 Publication type: Review in national publication Authors: Montejo Gonzalez, Juan Carlos, Sanchez Alvarez, Carmen, Perez de la Cruz, Antonio, Molina Soria, Juan Bautista, Matos Adames, Alfredo, Garcia Luna, Pedro Pablo, Burgos Pelaez, Rosa, Escudero Alvarez, Elena, Garcia Almeida, Jose Manuel, Garcia de Lorenzo, Abelardo et al. DOI: 10.3305/nh.2015.32.2.9324 [PHARMACONUTRITION IN SEVERELY ILL PATIENT]. PMID: 26268074 Journal: NUTR HOSP Year: 2015 Reference: Nutr Hosp. 2015 Aug 1;32(2):478-86. doi: 10.3305/nh.2015.32.2.9324. Impact factor: Publication type: Review in national publication Authors: Burgos Pelaez, Rosa; Escudero Alvarez, Elena; Garcia Almeida, Jose Manuel; Garcia de Lorenzo, Abelardo; Garcia Luna, Pedro Pablo; Gil Hernandez, Angel; Matos Adames, Alfredo; Molina Soria, Juan Bautista; Montejo Gonzalez, Juan Carlos; Perez de la Cruz, Antonio et al. DOI: 10.3305/nh.2015.32.2.9324 Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors. PMID: 26324363 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2015 Reference: J Clin Oncol. 2015 Oct 20;33(30):3401-8. doi: 10.1200/JCO.2014.60.7341. Epub 2015 Aug 31. Impact factor: 18.428 Publication type: Paper in international publication Authors: Zhong, Bob, Platero, Suso J, Smit, Johan W, Stuyckens, Kim, Chatterjee-Kishore, Moitreyee, Rodon, Jordi, Peddareddigari, Vijay, Luo, Feng R, Soria, Jean-Charles, Gazzah, Anas et al. DOI: 10.1200/JCO.2014.60.7341 Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors. PMID: 26324363 Journal: J CLIN ONCOL Year: 2015 Reference: J Clin Oncol. 2015 Oct 20;33(30):3401-8. doi: 10.1200/JCO.2014.60.7341. Epub 2015 Aug 31. Impact factor: Publication type: Paper in international publication Authors: Adamo, Barbara; Bahleda, Rastislav; Calvo, Emiliano; Chatterjee-Kishore, Moitreyee; Dienstmann, Rodrigo; Gazzah, Anas; Infante, Jeffrey R; Italiano, Antoine; Luo, Feng R; Mita, Alain et al. DOI: 10.1200/JCO.2014.60.7341 Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer. PMID: 25989270 Journal: BRITISH JOURNAL OF CANCER Year: 2015 Reference: Br J Cancer. 2015 Jun 9;112(12):1874-81. doi: 10.1038/bjc.2015.144. Epub 2015 May 19. Impact factor: 4.836 Publication type: Paper in international publication Authors: Macarulla, T, Cervantes, A, Tabernero, J, Rosello, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B et al. DOI: 10.1038/bjc.2015.144 Pagination First page « First Previous page ‹ Previous … Page 1236 Page 1237 Page 1238 Page 1239 Current page 1240 Page 1241 Page 1242 Page 1243 Page 1244 … Next page Next › Last page Last »
